Clinical Trials in Michigan

Showing 8101-8120 of 16,154 trials

A Phase 2 Study of CIM331 for Atopic Dermatitis Patients

NCT01986933

To assess the safety, tolerability and efficacy of CIM331, compared to placebo, in atopic dermatitis patients who are inadequately controlled by or intolerant to topical therapy

Atopic Dermatitis

Chugai Pharmaceutical264 participantsStarted Nov 2013

Anniston, Alabama, United States • San Diego, California, United States • Miami, Florida, United States +15 more locations

COMPLETEDPhase 337 miles

A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea

NCT03276936

The primary objective is to show that open-label extended treatment with FMX103 1.5%, for up to an additional 40 weeks, is safe and well tolerated.

Papulopustular Rosacea

Vyne Therapeutics Inc.504 participantsStarted Sep 2017

Glendale, Arizona, United States • Hot Springs, Arkansas, United States • Rogers, Arkansas, United States +76 more locations

A Phase 2 Study of CIM331 for Atopic Dermatitis Patients

A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea

Find Trials by Condition in Michigan

A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)

A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)

A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes

Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis

Study of TV-1106 in Growth Hormone-Deficient Adults

Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients

Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)

Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)

Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia

Cook IVC Filter Study

A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD

PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training

Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance

UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder

rTMS for Depressed Teens: A Sham-Controlled Trial, Part 1

rTMS for Depressed Teens: A Sham-Controlled Trial, Part 2

PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

Argus® II Retinal Stimulation System Feasibility Protocol